Daniel Bazarko, SVP, Controller, CAO at ALEXION PHARMACEUTICALS, INC. (ALXN), sold 37,132 shares at $157.59 ($5.9M) on 2020-12-17, disclosed to the SEC on 2020-12-21.
Open-market sale of $5.9M ALXN by SVP, Controller, CAO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $157.59 | 9,900 | $1.6M | 26.6% |
| 2 | $157.76 | 13,066 | $2.1M | 35.2% |
| 3 | $157.76 | 13,066 | $2.1M | 35.2% |
| 4 | $158.00 | 1,100 | $174K | 3.0% |
| Total | $157.72 avg | 37,132 | $5.9M | 100% |